[Chronic Epstein-Barr virus infection].
Imashuku
Shinsaku
S
Division of Pediatrics, Takasago-Seibu Hospital.
Teramura
Tomoko
T
D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology / Q000821:virology; D002869:Chromosome Aberrations; D002908:Chronic Disease; D016207:Cytokines / Q000378:metabolism; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy / Q000821:virology*; D015329:Gene Rearrangement, T-Lymphocyte; D016679:Genome, Viral; D018380:Hematopoietic Stem Cell Transplantation; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology / Q000821:virology; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology; D017735:Virus Latency
D000914:Antibodies, Viral; D000998:Antiviral Agents; D016207:Cytokines; D007166:Immunosuppressive Agents